December 5 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev has acquired 9,700 shares in the company at a weighted average price per share of 3.4402 levs ($1.95/1.76 euro) on December 4.
Donev Investments Holding, controlled by Donev, also acquired 200 shares in Sopharma at a weighted average price per share of 3.42 levs on December 4, Sopharma said in a bourse filing.
At the end of September, Donev held a stake of below 5% in Sopharma, while Donev Investments Holding owned 25.39%.
Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.
As at 12:00 CET on Thursday, Sopharma shares traded at 3.45 levs, unchanged from their previous closing price on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)